Applications are invited for a Group Leader in the UK Dementia Research Institute (DRI) at the University of Cambridge, Department of Clinical Neurosciences, Cambridge Biomedical Campus.
The mission of the UK DRI at the University of Cambridge, led by Professor Mina Ryten, is to create a collaborative, inter-disciplinary Centre that combines world-leading expertise across cell biology, chemistry, transcriptomics and genetics to understand the mechanisms driving neurodegeneration. We study all stages of disease in order to identify therapeutic targets with the greatest potential to treat dementia. Our existing research themes encompassing protein aggregation and clearance, ER dynamics, autophagy, DNA repair and transcriptomics, have already been highly successful and we intend to build on this momentum by continuing to recruit talented scientists.
We are looking for a clinical or non-clinical researcher to lead an individual internationally competitive research programme into neurodegeneration within the UK DRI here at Cambridge. We seek creative and innovative proposals for a new research programme in areas including but not limited to: the genetics of neurodegenerative disorders, the application of 'Omics technologies to the study of neurodegenerative disorders and the development of computational methods with a particular focus on integrative approaches.
For questions relating to the post, please contact Professor Mina Ryten at mr2022@cam.ac.uk for an informal and confidential discussion about the role.
Fixed-term: The funds for this post are available for 5 years in the first instance.
Key details
- Location UK DRI at Cambridge
- Salary: £46,735-£59,139
- Lab: Prof Mina Ryten